IBC Legal is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Paul Csiszár

Competition Law in the Pharmaceutical Sector: A View from the Commission

European Commission

Dec 04
Show Filter
08:30 - 09:00 30 mins
Registration
09:00 - 09:10 10 mins
Chair’s Welcome and Introduction
  • Brian Sher - Partner, Co-head of Competition, CMS
09:10 - 09:55 45 mins
Competition Law in the Pharmaceutical Sector: A View from the Commission
  • Paul Csiszár - Director Basic Industries, Manufacturing and Agriculture, DG Competition, European Commission
09:55 - 10:40 45 mins
Info
Review of Recent Excessive Pricing Cases
  • Ingrid Vandenborre - Partner, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
  • David Hull - Partner, Van Bael & Bellis
  • Review of Pfizer and Flynn and Aspen Italy decision
  • The applicable test
  • Pitfalls and difficulties in assessing and enforcing theories of harm based on excessive pricing
  • Related theories of harm
  • Practical strategies to reduce your competition law risk
10:40 - 11:00 20 mins
Morning Coffee Break
11:00 - 11:30 30 mins
Info
Economics of Excessive Pricing
  • Vivek Mani - Principal, Cornerstone Research
  • What is unfair pricing?
  • Economic analysis of excessive pricing
11:30 - 12:30 60 mins
Info
Rebates and Discounts: Strategies to Address Practical Challenges
  • Moderator Rameet Sangha - Director, AlixPartners
  • Nicolas Pourbaix - Senior Counsel, Amgen
  • Jacob Westin - Legal Counsel, Shire
  • Angela Staunton - VP Antitrust, Bayer Pharmaceuticals
  • Laetitia Szaller - Associate General Counsel, UCB
  • When are discounts and rebates problematic?
  • Review of recent decisions
  • Practical strategies to reduce risks
12:30 - 13:30 60 mins
Lunch
13:30 - 14:15 45 mins
Info
Reverse Patent Settlements
  • Geoff Steadman - Project Director, Competition & Markets Authority (CMA)
  • Brian Sher - Partner, Co-head of Competition, CMS
  • UK Paroxetine CAT judgement and CJEU reference
  • Update on Lundbeck and Servier 
15:00 - 15:45 45 mins
Info
Biologics & Biosimilars: Competition Law Challenges
  • David Hull - Partner, Van Bael & Bellis
  • Bill Batchelor - Partner, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
  • What are biologics and biosimilars?
  • How do you define the market?
  • Lifecycle management: should competition law treat biosimilars differently than generics?
  • Implications for mergers and remedies?
15:45 - 16:05 20 mins
Afternoon Coffee
16:05 - 16:45 40 mins
Info
Merger Control in the Pharmaceutical Sector
  • Axel Schulz - Partner, White & Case LLP
  • Tilman Kuhn - Partner, White & Case
  • Trends in the pharma sector 
  • Mergers and innovation after Dow/Du Pont 
  • Procedural developments: How is the Commission approaching mergers in the sector?  
  • Remedies
  • Threshold changes in Austria and Germany
16:45 - 17:30 45 mins
Info
Parallel Trade: Imports & Exports
  • Iona McCall - Senior Vice President, AlixPartners
  • Pat Treacy - Partner, Bristows
  • Heinz Kobelt - Director European Affairs, Association of Euro-Pharmaceutical Companies (EAEPC)
  • Is the Commission planning an investigation into parallel trade?
  • When is dual pricing permissible?
  • Review of key recent cases at member state level
17:30 - 17:35 5 mins
Chair's Closing Remarks and Close of Conference